Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?

被引:9
|
作者
Ouaalaya, El Hassane [1 ]
Falque, Laurent [3 ]
Dupis, Jean Michel [4 ]
Sabatini, Marielle [5 ]
Bernady, Alain [6 ]
Nguyen, Laurent [7 ]
Ozier, Annaig [7 ]
Nocent-Ejnaini, Cecilia [5 ]
Le Guillou, Frederic [8 ]
Molimard, Mathieu [9 ]
Zysman, Maeva [10 ]
Raherison-Semjen, Chantal [1 ,2 ]
机构
[1] Bordeaux Univ, Bordeaux Populat Hlth Res Ctr, UMR1219, Team EPICENE,INSERM, Bordeaux, France
[2] CHU Bordeaux, Pole Cardiothorac, Resp Dis Dept, Bordeaux, France
[3] Polyclin Bordeaux Rive Droite, Lormont, France
[4] Cabinet Med Pessac, Pessac, France
[5] CHG Cote Basque, Bayonne, France
[6] Med Ctr TOKI EDER, Cambo Les Bains, France
[7] Polyclin St Augustin, Bordeaux, France
[8] Cabinet Med, La Rochelle, France
[9] Bordeaux Univ, Bordeaux Populat Hlth Res Ctr, Team Pharmacoepidemiol, INSERM,UMR 1219, Bordeaux, France
[10] Bordeaux Univ, Cardiothorac Res Ctr Bordeaux, UMR1045, Team 2,INSERM, Bordeaux, France
关键词
COPD Phenotypes; Frequent exacerbator; Cluster analysis; Longitudinal analysis; OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; INFLUENZA VACCINATION; HOSPITALIZATION; FLUTICASONE; PREVENTION; MORTALITY;
D O I
10.1016/j.rmed.2020.106018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Exacerbations are key events in the natural history of COPD, but our understanding of their longitudinal determinants remains unclear. We used data from a large observational study to test the hypothesis that vaccination status and comorbidities could be associated with the occurrence of exacerbations profile. Methods: Diagnosed COPD patients have been included by their pulmonologists, with up to 3 years of follow-up. Data were analyzed using the KmL method designed to cluster longitudinal data and receiver operating characteristic curve analysis to determine the best threshold to allocate patients to identified clusters. Results: 932 COPD patients were included since January 2014, 446 patients (65.68% males, 35.59% current smokers) were followed over a period of 3 years with complete data. 239(28.15%) patients reported two or more exacerbations in the year before enrolment (frequent exacerbations). Among them 142(16.68%) also had frequent exacerbations in the first year of the study, and 69(8.10%) who remained frequent exacerbators in the second year. Based on our hypothesis, we were able to determine four phenotypes: A (infrequent), B (frequent in underweight patients), C (transient), and D (frequent in obese patients). Frequent exacerbators had more airflow limitation and symptoms. Irrespective of cut-offs set to define the optimal number of clusters, a history of exacerbations OR: 3.72[2.53-5.49], presence of anxiety OR: 2.03[1.24-3.31] and absence of the annual influenza vaccination OR: 1.97[1.20-3.24] remained associated with the frequent exacerbator phenotypes. Conclusions: The most important determinants of frequent exacerbations are a history of exacerbations, anxiety and unvaccinated against influenza.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations
    Scioscia, Giulia
    Blanco, Isabel
    Arismendi, Ebymar
    Burgos, Felip
    Gistau, Concepcion
    Barbaro, Maria Pia Foschino
    Celli, Bartolome
    O'Donnell, Denis E.
    Agusti, Alvar
    THORAX, 2017, 72 (02) : 117 - 121
  • [22] In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
    Worth, Heinrich
    Buhl, Roland
    Criee, Carl-Peter
    Kardos, Peter
    Gueckel, Eva
    Vogelmeier, Claus F.
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [23] In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
    Heinrich Worth
    Roland Buhl
    Carl-Peter Criée
    Peter Kardos
    Eva Gückel
    Claus F. Vogelmeier
    Respiratory Research, 24
  • [24] Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients
    Jeong, Suk Hyeon
    Lee, Hyun
    Carriere, K. C.
    Shin, Sun Hye
    Moon, Seong Mi
    Jeong, Byeong-Ho
    Koh, Won-Jung
    Park, Hye Yun
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1857 - 1865
  • [25] The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
    Atis, Sibel
    Ozgur, Eylem
    Ozge, Cengiz
    Duman, Yasin
    Tastekin, Esin
    Ilvan, Ahmet
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [26] The Impact of Air Pollution on Frequent Exacerbations among COPD Patients: An Observational Study on the Population of Western Romania
    Bala, Gabriel-Petrica
    Timar, Bogdan
    Gorun, Florin
    Motisan, Radu
    Pescaru, Camelia
    Tudorache, Emanuela
    Marc, Monica
    Manolescu, Diana
    Citu, Cosmin
    Oancea, Cristian
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [27] Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
    Lenferink, Anke
    van der Palen, Job
    van der Valk, Paul D. L. P. M.
    Cafarella, Paul
    van Veen, Anneke
    Quinn, Stephen
    Groothuis-Oudshoorn, Catharina G. M.
    Burt, Morton G.
    Young, Mary
    Frith, Peter A.
    Effing, Tanja W.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (05)
  • [28] Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population
    Marott, Jacob Louis
    Colak, Yunus
    Ingebrigtsen, Truls Sylvan
    Vestbo, Jorgen
    Nordestgaard, Borge Gronne
    Lange, Peter
    RESPIRATORY MEDICINE, 2022, 192
  • [29] COPD Patients With Chronic Purulent Sputum Have More Frequent COPD Exacerbations And Require More Frequent Treatment With Antibiotics
    Krahnke, J. S.
    Grabianowski, C. L.
    Katamreddy, S. R.
    Gaughan, J. P.
    Criner, G. J.
    Kim, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [30] Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations
    Halpin, David M. G.
    Healey, Heath
    Skinner, Derek
    Carter, Victoria
    Pullen, Rachel
    Price, David
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64 (04)